AVXL
ANAVEX LIFE SCIENCES CORP.
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Net Income
$-46377000
↓ 7.8%
Total Assets
$103.8M
↓ 23.4%
Operating Income
$-51408000
↑ 2.8%
Total Liabilities
$8.9M
↓ 41.5%
EPS (Diluted)
$-0.54
↓ 3.8%
Cash & Equivalents
$102.6M
↓ 22.4%
Shareholders' Equity
$94.9M
↓ 21.1%
Operating Cash Flow
$-39044000.00
↓ 26.7%

Recent SEC Filings

Form Type Filed Date Link
DEFA14A 8/11/2026 View on SEC
8-K 8/11/2026 View on SEC
DEFC14A 8/11/2026 View on SEC
NT 10-Q 8/10/2026 View on SEC
8-K 8/3/2026 View on SEC
PREC14A 7/31/2026 View on SEC
SCHEDULE 13G 7/31/2026 View on SEC
8-K 7/30/2026 View on SEC
PREC14A 7/24/2026 View on SEC
8-K 7/20/2026 View on SEC

Company Information

Field Value
Ticker AVXL
Company Name ANAVEX LIFE SCIENCES CORP.
CIK 1314052
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 0930
Phone 844-689-3939